Accelr8's Q3 Revenues Jump on Development Fees

Jun 20, 2011

NEW YORK (GenomeWeb News) – Accelr8 Technology has reported that its third-quarter revenues jumped sharply from $19,873 to $240,272 year over year.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.